Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01364818 · ClinicalTrials.gov registry record
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 25
- Enrollment target
NCT01364818: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT01364818 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01364818 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of the proposed research is to study the potential changes in biomarkers of patients with neurodevelopmental disorders in response to treatment in clinical trials or in private psychiatry practice utilizing non-invasive psychophysiological measurements. The investigators plan to obtain psychophysical measurements throughout several periods of treatment.
Primary Outcome
The primary analyses will examine whether the pre-post treatment difference in the effect of confounding stimuli (eg. ratio of confounded stimuli/control stimuli) on amplitude discrimination varies between the two groups (active treatment, no active treatment group) using an unpaired t test.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-12 |
What the finished NCT01364818 record still lists
NCT01364818 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01364818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01364818 about?
NCT01364818 is a clinical study titled "Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment". The purpose of the proposed research is to study the potential changes in biomarkers of patients with neurodevelopmental disorders in response to treatment in clinical trials or in private psychiatry practice utilizing non-invasive psychophysiological measurements. The investigators plan to obtain p...
What is the current status of trial NCT01364818?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2011-09. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01364818?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia